Moderador(es)
Presentaciones de la sesión
14:12
PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus
14:58
The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong
15:08
New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel